A Common Vitamin Could Hold the Key to Treating Fatty Liver Disease

From SciTechDaily

About 30% of people worldwide are affected by metabolic-associated fatty liver disease (MASLD), a condition closely tied to obesity and type 2 diabetes that can quietly progress to liver damage. Despite its growing impact, treatment options remain limited. New research now points to an unexpected target, and a familiar vitamin, that could help change that.

A team led by Jang Hyun Choi at UNIST, in collaboration with Hwayoung Yun at Pusan National University and Neung Hwa Park at Ulsan University Hospital, has identified a small RNA molecule called microRNA-93 (miR-93) as a central driver of the disease. Their findings show that this molecule acts like a molecular switch that disrupts how the liver processes fat.